XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (7,210,560) $ (6,577,816)
Adjustments to reconcile net loss to cash used in operating activities    
Change in fair value of warrant liability (858)
Change in fair value of investment option liability (1,707)
Loss on write-off of deferred offering costs 19,597
Stock based compensation 412,333 587,089
Amortization of intangibles 42,180
Depreciation expense 108,985 119,193
Other (128,683)
Change in operating assets and liabilities:    
Due to related parties (94,875) (232,891)
Prepaid expenses and other current assets (415,847) 132,795
Accounts payable, accrued expenses and other current liabilities (171,979) (295,982)
Net cash used in operating activities (7,352,346) (6,356,680)
Cash Flows From Financing Activities:    
Proceeds from sale of Common Stock and warrants, net of offering costs 5,552,765 4,244,467
Proceeds from Common Stock sold for cash pursuant to the ATM Agreement, net of offering costs 1,291,038 1,636,799
Payment of deferred offering costs (47,947)
Proceeds from exercise of warrants 1,523,296 2,009,095
Net cash provided by financing activities 8,319,152 7,890,361
Effect of foreign exchange rate on changes on cash (31,309) (17,113)
Net increase in cash 935,497 1,516,568
Cash at beginning of period 4,677,491 2,241,026
Cash at end of period 5,612,988 3,757,594
Supplemental disclosure of cash flow transactions:    
Cash paid for interest
Income taxes paid 3,000
Non-cash financing and investing activities:    
Non-cash issuance of round-up shares 73
Non-cash issuance of RSA vested shares 12
Issuance of Placement Agent Warrants as offering costs 286,000 237,564
Offering costs accrued not paid 49,837
Deferred offering costs not paid 4,394 33,624
Deemed dividend on inducement of warrants $ 1,513,449